S. Kocoglu Et Al. , "Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells," ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3, pp.217-226, 2022
Kocoglu, S. Et Al. 2022. Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells. ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3 , 217-226.
Kocoglu, S., Secme, M., & Elmas, L., (2022). Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells. ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3, 217-226.
Kocoglu, SEMA, Mucahit Secme, And Levent Elmas. "Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells," ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3, 217-226, 2022
Kocoglu, SEMA S. Et Al. "Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells." ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3, pp.217-226, 2022
Kocoglu, S. Secme, M. And Elmas, L. (2022) . "Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells." ARCHIVES OF BIOLOGICAL SCIENCES , vol.74, no.3, pp.217-226.
@article{article, author={SEMA SERTER KOÇOĞLU Et Al. }, title={Erianin, a promising agent in the treatment of glioblastoma multiforme triggers apoptosis in U373 and A172 glioblastoma cells}, journal={ARCHIVES OF BIOLOGICAL SCIENCES}, year=2022, pages={217-226} }